Lupin Ltd. | LUPIN | NSE - Pharmaceuticals


INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.

 Chart
2017
2018
2019
2020
2021
Revenue
Revenue
174,943158,042167,182153,748151,630
Cost of revenue
Cost of revenue
-50,014-52,744-58,458-54,306-53,622
Gross Profit
Gross Profit
124,929
105,298
108,724
99,442
98,007
Sales, general & ad...
Sales, general and administrative
-79,998-73,822-79,902-75,894-72,338
Depreciation
Depreciation and amortization
-9,122-10,859-10,850-9,702-8,874
Provision
Provision
00000
Other op inc/exp...
Other operating income/expenses
00000
Operating income
Operating income EBIT
35,809
20,616
17,972
13,846
16,795
 
      
Interest expense
Interest expense
-1,525-2,044-3,078-3,630-1,406
Other income/exp...
Other income(expense)
1,065-13,140240-2,6831,363
Profit before tax
Profit before tax
35,349
5,433
15,134
7,533
16,751
Income tax & other ta...
Income tax and other taxes
9,7852,8859,01711,5714,485
Net income from c...
Net income from continuing operations
25,5642,5486,117-4,03812,266
Extraordinary & disc...
Extraordinary items & Discontinued Ops
0001,3010
Share of associates
Share of associates
8335384313
Minority Interest
Minority Interest
-72-71-960-114
Net Income
Net income
25,575
2,513
6,059
-2,694
12,165
 
      
NI - Preferred Di...
Net Income after Preferred Dividend and Others
25,5752,5136,059-2,69412,165
Basic shares
Basic shares
451452452453453
Diluted Shares
Diluted Shares
453453454455455
EPS Basic
EPS Basic in Rupees
56.695.5613.40-5.9526.87
EPS Diluted
EPS Diluted in Rupees
56.46
5.54
13.34
-5.95
26.73